Johnson & Johnson Company

baby powder, Johnson and link to cancer

Johnson & Johnson legal battle over baby powder's 'link to cancer' begins in $10 billion case

A $10 billion settlement to end litigation over Johnson & Johnson's baby powder, which was recalled after it was alleged to cause cancer in women, will be put to a judge on Tuesday

The Mirror US on MSN · 1d

Johnson & Johnson begins battle over baby powder's 'link to cancer' in $10 billion case

Johnson & Johnson is beginning its third legal battle over its baby powder product's alleged link to ovarian cancer in more than 62,000 women across the country in a $10 billion case

Reuters · 2d

J&J begins crucial battle over $10 billion baby powder settlement

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on its third attempt to resolve thousands of lawsuits through a subsidiary's bankruptcy.

1don MSN

Johnson & Johnson Goes to Trial on Third Talc Bankruptcy Plan

Healthcare conglomerate Johnson & Johnson kicks off its bankruptcy plan confirmation Tuesday, in its third attempt to resolve ...

Johnson & Johnson (JNJ) Plans $1 Billion Sale of ‘Cerenovus’ Stroke Unit

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

New York Post7d

Johnson & Johnson halts late-stage E.coli vaccine trial after poor results

Pharmaceutical giants Johnson & Johnson and Sanofi have stopped ... review of the data found no safety issues, and the company is now conducting follow-ups with participants who had already ...

3don MSN

Why Johnson & Johnson (JNJ) Is One of the Best Drug Stocks to Buy Now

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Johnson & Johnson (JNJ) Receives a Buy from RBC Capital

In a report released yesterday, Shagun Singh Chadha from RBC Capital initiated coverage with a Buy rating on Johnson & Johnson (JNJ – ...

AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant

Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each ...

ETF Daily News5d

Johnson & Johnson (NYSE:JNJ) Shares Sold by GEM Asset Management LLC

Check Out Our Latest Report on Johnson & Johnson Johnson & Johnson Stock Down 0.7 % NYSE JNJ opened at $156.20 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.03 and a ...

Benzinga.com8d

Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates

Johnson & Johnson JNJ is reportedly considering selling its stroke care unit, Cerenovus, in a deal that could value the ...

Johnson & Johnson: Rich History Of Excellence Poised To Endure

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

ETF Daily News5d

Jmac Enterprises LLC Cuts Stake in Johnson & Johnson (NYSE:JNJ)

The fund owned 13,249 shares of the company’s stock after selling 800 shares during the period. Jmac Enterprises LLC’s holdings in Johnson & Johnson were worth $1,916,000 as of its most recent ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results